Patents by Inventor David R. Holmes, Jr.

David R. Holmes, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058057
    Abstract: Devices and methods can be used to treat of heart conditions, hypertension, and other medical disorders. For example, devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation are described herein. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 22, 2024
    Inventors: Samuel J. Asirvatham, David R. Holmes, JR.
  • Patent number: 11844565
    Abstract: This document provides devices and methods for the treatment of heart conditions, hypertension, and other medical disorders. For example, this document provides devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: December 19, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, David R. Holmes, Jr.
  • Publication number: 20220346870
    Abstract: Devices and methods for the treatment of heart conditions, hypertension, and other medical disorders are described. For example, this document describes devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation. Additionally, in some embodiments, particulate matter, such as thrombus or crystalline drug compounds, created during the ablation is captured and removed from the patient using devices and methods provided herein. Further, devices and methods for non-thermal methods of causing cell death, such as tissue suction and tissue stretching, are also described.
    Type: Application
    Filed: July 18, 2022
    Publication date: November 3, 2022
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: David R. Holmes, JR., Samuel J. Asirvatham, Christopher V. DeSimone
  • Publication number: 20190336208
    Abstract: This document provides devices and methods for the treatment of heart conditions, hypertension, and other medical disorders. For example, this document provides devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation.
    Type: Application
    Filed: July 12, 2019
    Publication date: November 7, 2019
    Inventors: Samuel J. Asirvatham, David R. Holmes, JR.
  • Patent number: 10390879
    Abstract: This document provides devices and methods for the treatment of heart conditions, hypertension, and other medical disorders. For example, this document provides devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: August 27, 2019
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, David R. Holmes, Jr.
  • Publication number: 20180360531
    Abstract: Devices and methods for the treatment of heart conditions, hypertension, and other medical disorders are described. For example, this document describes devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation. Additionally, in some embodiments, particulate matter, such as thrombus or crystalline drug compounds, created during the ablation is captured and removed from the patient using devices and methods provided herein. Further, devices and methods for non-thermal methods of causing cell death, such as tissue suction and tissue stretching, are also described.
    Type: Application
    Filed: October 25, 2016
    Publication date: December 20, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: David R. Holmes, Jr., Samuel J. Asirvatham, Christopher V. DeSimone
  • Publication number: 20170281193
    Abstract: Devices and methods can be used to treat heart conditions. Some such devices include endocardial occlusion and ablation devices. For example, such devices can be used for closing and ablating the left atrial appendage to treat atrial fibrillation and to reduce the potential for embolic stroke. In addition, this document provides devices and methods for closing and ablating other body viscera, conduits, valves, and the like.
    Type: Application
    Filed: August 26, 2015
    Publication date: October 5, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, David R. Holmes, Jr.
  • Publication number: 20160374754
    Abstract: This document provides devices and methods for the treatment of heart conditions, hypertension, and other medical disorders. For example, this document provides devices and methods for treating atrial fibrillation by performing thoracic vein ablation procedures, including pulmonary vein myocardium ablation. In some embodiments, the ablation is performed in coordination with the delivery a pharmacological agent that can abate the formation of tissue stenosis or neointimal hyperplasia caused by the ablation.
    Type: Application
    Filed: May 20, 2014
    Publication date: December 29, 2016
    Inventors: Samuel J. Asirvatham, David R. Holmes, Jr.
  • Patent number: 9414762
    Abstract: Some embodiments of a mapping device may be capable of passing through cerebral veins and other cerebrovascular spaces to provide electrophysiological mapping of the brain. These embodiments of the device may also be capable of providing, simultaneously or separately, ablation energy or other treatments to targeted brain tissue. In such circumstances, a user may be enabled to analyze an electrophysiological map of a patient's brain and, at the same time or within a short time period before or after the mapping process, may be enabled to apply ablation energy for treatment of a central nervous system disorder. Such treatment may be accomplished without the use of invasive surgery in which the brain is accessed through an opening in the patient's cranium.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: August 16, 2016
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Paul A. Friedman, Charles J. Bruce, David R. Holmes, Jr.
  • Publication number: 20160082234
    Abstract: An apparatus and method of use are disclosed for treating, preventing and terminating arrhythmias. In particular, the apparatus is implantable within or on various tissues and structures and is used to prevent or block conduction of aberrant impulses. A variety of methods of the present invention may be used to attack arrhythmias by short-circuiting impulses, inducing fibrosis, ablating tissue or inducing inflammation. In addition, the device and methods may also be used to treat aneurysms. The device may also be used to treat hypertension, and to function as a blood pressure regulator.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Applicant: Syntach AG
    Inventors: Robert S. Schwartz, Robert A. Van Tassel, David R. Holmes, JR.
  • Publication number: 20140296680
    Abstract: Some embodiments of a mapping device may be capable of passing through cerebral veins and other cerebrovascular spaces to provide electrophysiological mapping of the brain. These embodiments of the device may also be capable of providing, simultaneously or separately, ablation energy or other treatments to targeted brain tissue. In such circumstances, a user may be enabled to analyze an electrophysiological map of a patient's brain and, at the same time or within a short time period before or after the mapping process, may be enabled to apply ablation energy for treatment of a central nervous system disorder. Such treatment may be accomplished without the use of invasive surgery in which the brain is accessed through an opening in the patient's cranium.
    Type: Application
    Filed: June 13, 2014
    Publication date: October 2, 2014
    Inventors: Samuel J. Asirvatham, Paul A. Friedman, Charles J. Bruce, David R. Holmes, JR.
  • Publication number: 20140052169
    Abstract: An apparatus and method of use are disclosed for treating, preventing and terminating arrhythmias. In particular, the apparatus is implantable within or on various tissues and structures and is used to prevent or block conduction of aberrant impulses. A variety of methods of the present invention may be used to attack arrhythmias by short-circuiting impulses, inducing fibrosis, ablating tissue or inducing inflammation. In addition, the device and methods may also be used to treat aneurysms. The device may also be used to treat hypertension, and to function as a blood pressure regulator.
    Type: Application
    Filed: October 28, 2013
    Publication date: February 20, 2014
    Applicant: Syntach AG
    Inventors: Robert S. Schwartz, Robert A. Van Tassel, David R. Holmes, JR.
  • Patent number: 8579955
    Abstract: An apparatus and method of use are disclosed for treating, preventing and terminating arrhythmias. In particular, the apparatus is implantable within or on various tissues and structures and is used to prevent or block conduction of aberrant impulses. A variety of methods of the present invention may be used to attack arrhythmias by short-circuiting impulses, inducing fibrosis, ablating tissue or inducing inflammation. In addition, the device and methods may also be used to treat aneurysms. The device may also be used to treat hypertension, and to function as a blood pressure regulator.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: November 12, 2013
    Assignee: Syntach AG
    Inventors: Robert S. Schwartz, Robert A. Van Tassel, David R. Holmes, Jr.
  • Patent number: 8544474
    Abstract: Systems and methods that provide magnetically-enhanced delivery of therapeutic agents to selected tissue are disclosed. The systems and methods involve the use of carrier devices and release devices and two different magnetic fields to move magnetic particles into selected tissue. Movement of the magnetic particles (and any associated therapeutic agent) into the tissue may be assisted by both magnetic attractive forces as well as magnetic repulsive forces.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: October 1, 2013
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Gurpreet S. Sandhu, David R. Holmes, Jr., Robert D. Simari, Nicole P. Sandhu, David R. Holmes, III
  • Publication number: 20130211537
    Abstract: Medical devices, such as endoprostheses, and methods of making the devices are disclosed. The endoprostheses comprise a tubular member capable of maintaining patency of a bodily vessel. The tubular member includes a duplex stainless steel (e.g., 2205 stainless steel), which may be magnetized.
    Type: Application
    Filed: May 24, 2011
    Publication date: August 15, 2013
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Gurpreet S. Sandhu, Robert D. Simari, David R. Holmes, JR., Dan Dragomir-Daescu, Anthony P. Parakka
  • Publication number: 20120220890
    Abstract: Some embodiments of a mapping device may be capable of passing through cerebral veins and other cerebrovascular spaces to provide electrophysiological mapping of the brain. These embodiments of the device may also be capable of providing, simultaneously or separately, ablation energy or other treatments to targeted brain tissue. In such circumstances, a user may be enabled to analyze an electrophysiological map of a patient's brain and, at the same time or within a short time period before or after the mapping process, may be enabled to apply ablation energy for treatment of a central nervous system disorder. Such treatment may be accomplished without the use of invasive surgery in which the brain is accessed through an opening in the patient's cranium.
    Type: Application
    Filed: May 10, 2012
    Publication date: August 30, 2012
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Samuel J. Asirvatham, Paul A. Friedman, Charles J. Bruce, David R. Holmes, JR.
  • Patent number: 8204600
    Abstract: Some embodiments of a mapping device may be capable of passing through cerebral veins and other cerebrovascular spaces to provide electrophysiological mapping of the brain. These embodiments of the device may also be capable of providing, simultaneously or separately, ablation energy or other treatments to targeted brain tissue. In such circumstances, a user may be enabled to analyze an electrophysiological map of a patient's brain and, at the same time or within a short time period before or after the mapping process, may be enabled to apply ablation energy for treatment of a central nervous system disorder. Such treatment may be accomplished without the use of invasive surgery in which the brain is accessed through an opening in the patient's cranium.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: June 19, 2012
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Paul A. Friedman, Charles J. Bruce, David R. Holmes, Jr.
  • Publication number: 20110178539
    Abstract: This document provides methods and materials related to minimally invasive techniques for reducing the volume of and/or occluding left atrial appendages.
    Type: Application
    Filed: July 8, 2009
    Publication date: July 21, 2011
    Inventors: David R. Holmes, Jr., David R. Holmes, III, Paul A. Friedman, Charles J. Bruce, Samuel J. Asirvatham, Susan B. Johnson, Rebecca B. Fountain
  • Publication number: 20110144411
    Abstract: Systems and methods that provide magnetically-enhanced delivery of therapeutic agents to selected tissue are disclosed. The systems and methods involve the use of carrier devices and release devices and two different magnetic fields to move magnetic particles into selected tissue. Movement of the magnetic particles (and any associated therapeutic agent) into the tissue may be assisted by both magnetic attractive forces as well as magnetic repulsive forces.
    Type: Application
    Filed: December 19, 2008
    Publication date: June 16, 2011
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Gurpreet S. Sandhu, David R. Holmes, JR., Robert D. Simari, Nicole P. Sandhu
  • Patent number: 7727184
    Abstract: A catheter delivery system for delivering a treatment substance to an occlusion in a lumen of a tubular vessel includes a tubular catheter and a treatment substance. The tubular catheter includes a central lumen passing between a proximal end and a distal end adjacent to an inflatable balloon. The treatment substance is in a form that is configured to be deliverable through the central lumen of the catheter into the lumen of the tubular vessel and to solidify in the vessel.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: June 1, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: David R. Holmes, Jr., Robert S. Schwartz